<?xml version="1.0" encoding="UTF-8"?>
<ref id="bib0035">
 <label>7</label>
 <element-citation publication-type="book" id="sbref0035">
  <person-group person-group-type="author">
   <name>
    <surname>US Food &amp; Drugs Administration</surname>
   </name>
  </person-group>
  <chapter-title>Recommendations for investigational COVID-19 convalescent plasma</chapter-title>
  <year>2020</year>
  <ext-link ext-link-type="uri" xlink:href="https://www.fda.gov/vaccines-blood-biologics/investigational-new-drug-ind-or-device-exemption-ide-process-cber/investigational-covid-19-convalescent-plasma-emergency-inds" id="intr0010" xmlns:xlink="http://www.w3.org/1999/xlink">https://www.fda.gov/vaccines-blood-biologics/investigational-new-drug-ind-or-device-exemption-ide-process-cber/investigational-covid-19-convalescent-plasma-emergency-inds</ext-link>
 </element-citation>
</ref>
